1. L.W. Segars, B.J. Gales, Mesalamine and olsalazine: 5-aminosalicylic acid agents for the treatment of inflammatory bowel disease, Clini. Pharm. 11 (1992).
2. Rolling review: inflammatory bowel disease;Carpani de Kaski;Aliment. Pharmacol. Ther.,1993
3. Simplified high-performance liquid chromatographic method for 5-aminosalicylic acid in plasma and urine;Fischer;J. Chromatogr. Biomed. Appl.,1981
4. A rapid method for the simultaneous determination of the major metabolites of sulphasalazine in plasma;Shaw;J. Chromatogr. Biomed. Appl.,1983
5. R.O. Kringle, An assesment of the 4-6-20 Rule for acceptance of analytical runs in bioavailability, bioequivalence, and pharmacokinetics studies, Pharc. Res. 11 (4) (1994).